NLNi Li

Ni Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ni Li has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Haihe Wang

    Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, PR China

    1 shared publication
  • Jingjie Li

    Clinical Laboratory Medicine Department, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China

    1 shared publication
  • Jinyuan Wang

    Department of Clinical Laboratory The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University Wenzhou China

    1 shared publication
  • Lai Wei

    Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, PR China

    1 shared publication
  • Minghua Jiang

    Department of Clinical Laboratory, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China

    1 shared publication
  • Mingxiao Chen

    Joint Program in Pathology, Department of Internal Medicine, Guangzhou Women and Children’s Medical Center, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510623, PR China

    1 shared publication

Latest Publications

  • Open Access

    Genomic epidemiology, population structure and lineage-associated genomic variation in KPC-producing Pseudomonas aeruginosa

    by Tianci Zhou, Ni Li, Jingjie Li, Mingxiao Chen, Youqiang Li

    Objectives: KPC-producing Pseudomonas aeruginosa (KPC-PA) has emerged as an important multidrug-resistant pathogen, yet its population structure and lineage-associated genomic variation remain incompletely understood. We investigated the genomic epidemiology of an international collection of KPC-PA genomes to characterize population structure, evolutionary patterns, and lineage-associated genomic features. Methods: A complete genome of a clinical ST463 isolate (PA328) was generated using hybrid sequencing and analyzed together with 655 publicly available KPC-PA genomes. Comparative genomic, phylogenomic, pangenome, recombination, and Bayesian temporal analyses were performed to investigate population structure and identify genomic features associated with major lineages. Results: Among 656 KPC-PA genomes, bla KPC−2 (99.5%) and ST463 (43.6%) were predominant. Population genomic analysis resolved eight major phylogenetic lineages with distinct sequence-type compositions and geographic distributions, including ST463 in China, ST282 in the United States, and ST654 in Chile. Assembly-based screening identified candidate frameshift calls in genes annotated as being involved in metabolism, iron acquisition, transport, and virulence-associated functions, providing potential targets for further investigation using read-level confirmation. Descriptive analyses revealed lineage-associated patterns of antimicrobial resistance genes (ARGs) and mobile genetic elements co-occurrence. Within ST463, an operationally defined high-recombination region (HRR) contained genes annotated as being related to secretion systems, biofilm formation, metabolism, and mobile genetic elements. Bayesian analysis estimated the time to the most recent common ancestor (tMRCA) of the sampled Chinese ST463 population at approximately 2005. Partial similarity between plasmid sequences and the HRR suggested potential evolutionary connections, although their specific relationship requires further investigation. Conclusions: This study characterizes the population structure and lineage-associated genomic variation of KPC-PA within a large international genome collection. The findings provide a descriptive genomic resource for understanding KPC-PA evolution and surveillance, and highlight candidate genomic features that warrant further structure-aware analyses and experimental investigation.

  • Open Access

    The Prediction of Pre‐Eclampsia Using Low Fetal Fraction in a Machine Learning Model

    by Jinyuan Wang, Yuxiao Bai, Shengshan Huang, Yao Lin, Songdao Ye, Wangxiao Zhou, Shanshan Li, Ni Li, Minghua Jiang, Xiaoou Wang

    Objective: To investigate the association between low fetal fraction (FF) in non‐invasive prenatal testing (NIPT) and pregnancy complications or adverse pregnancy outcomes. Methods: Sixty‐four pregnant women undergoing NIPT at the Second Affiliated Hospital of Wenzhou Medical University between 13 June 2019 and 6 January 2023 had an initial NIPT failure due to low FF. Three cases were lost to follow‐up, leaving 61 cases in the failure group (Group A). Group A was subdivided into 37 cases with a valid result after redraw (Group A1) and 24 cases remaining unsuccessful after redraw (Group A2). Concurrently, 119 pregnancies with successful NIPT (normal FF, no fetal chromosomal abnormalities) were randomly selected as controls (Group C). Logistic regression and XGBoost models were established, and their area under the curve (AUC), sensitivity, and specificity were calculated and compared. Results: The incidence of pre‐eclampsia was significantly higher in Group A than in Group C ( p < 0.05). No significant difference in the incidence of pre‐eclampsia was found between Groups A1 and A2. A logistic regression model incorporating FF predicted pre‐eclampsia with an AUC of 0.750 (95% CI: 0.639–0.860), sensitivity of 0.875, and specificity of 0.727. An XGBoost model incorporating 10 factors (FF, age, weight, BMI, gestational age, systolic/diastolic blood pressure at sampling, ART history, delivery history, heparin use history) demonstrated superior performance (AUC = 0.956, 95% CI: 0.868–1.000; accuracy = 0.944). The top three important factors were systolic blood pressure, diastolic blood pressure, and FF. Conclusions: Low FF in NIPT may indicate an increased risk of pre‐eclampsia. Regardless of the success of redraw, pregnancies with initial NIPT failure due to low FF warrant vigilance for pre‐eclampsia development. The XGBoost machine learning model demonstrates good efficacy for predicting pre‐eclampsia and has potential as an adjunctive prenatal screening tool for early diagnosis.

  • Open Access

    Development of full-length cell-culture infectious clone and subgenomic replicon for a genotype 3a isolate of hepatitis C virus

    by Mingxiao Chen, Yi Xu, Ni Li, Ping Yin, Qing Zhou, Shengjun Feng, Tiantian Wu, Lai Wei, Haihe Wang, Yongshui Fu, et al.

    Hepatitis C virus (HCV) genotype 3 is widely distributed, and genotype 3-infected patients achieve a lower cure rate in direct-acting antiviral (DAA) therapy and are associated with a higher risk of hepatic steatosis than patients with other genotypes. Thus, the study of the virology and pathogenesis of genotype 3 HCV is increasingly relevant. Here, we developed a full-length infectious clone and a subgenomic replicon for the genotype 3a isolate, CH3a. From an infected serum, we constructed a full-length CH3a clone, however, it was nonviable in Huh7.5.1 cells. Next, we systematically adapted several intergenotypic recombinants containing Core-NS2 and 5′UTR-NS5A from CH3a, and other sequences from a replication-competent genotype 2 a clone JFH1. Adaptive mutations were identified, of which several combinations facilitated the replication of CH3a-JFH1 recombinants; however, they failed to adapt to the full-length CH3a and the recombinants containing CH3a NS5B. Thus, we attempted to separately adapt CH3a NS5B-3′UTR by constructing an intragenotypic recombinant using 5′UTR-NS5A from an infectious genotype 3a clone, DBN3acc, from which L3004P/M in NS5B and a deletion of 11 nucleotides (Δ11nt) downstream of the polyU/UC tract of the 3′UTR were identified and demonstrated to efficiently improve virus production. Finally, we combined functional 5′UTR-NS5A and NS5B-3′UTR sequences that carried the selected mutations to generate full-length CH3a with 26 or 27 substitutions (CH3acc), and both revealed efficient replication and virus spread in transfected and infected cells, releasing HCV of 104.2 f.f.u. ml−1. CH3acc was inhibited by DAAs targeting NS3/4A, NS5A and NS5B in a dose-dependent manner. The selected mutations permitted the development of subgenomic replicon CH3a-SGRep, by which L3004P, L3004M and Δ11nt were proven, together with a single-cycle virus production assay, to facilitate virus assembly, release, and RNA replication. CH3acc clones and CH3a-SGRep replicon provide new tools for the study of HCV genotype 3.